EYPT 8-K 2026-09-10
EyePoint, Inc. (EYPT) 8-K dated 2026-09-10 — accession 0001193125-26-387197.
EyePoint, Inc. (EYPT) is a biotechnology company listed on NASDAQ.
EyePoint, Inc. filed a 8-K on 2026-09-10. Accession 0001193125-26-387197.
This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported EYPT revenue for 2025-12-31 was $31.4M. Net income was -$232.0M. Revenue was down 27.5% from 2024-12-31 to 2025-12-31. EYPT currently screens at market cap $1.10B.
Not investment advice. The EYPT SEC hub lists recent forms. The stock page is the research view.